Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Chief Financial Officer Michael Rogers has left the company. David Lawrence, Acorda’s Chief ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE